Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin 
Quarterly Data

Microsoft Excel

Two-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Sep 30, 2025 27.43% = 16.60% × 1.65
Jun 30, 2025 27.65% = 16.64% × 1.66
Mar 31, 2025 27.66% = 16.58% × 1.67
Dec 31, 2024 28.12% = 16.46% × 1.71
Sep 30, 2024 14.49% = 7.76% × 1.87
Jun 30, 2024 14.13% = 7.61% × 1.86
Mar 31, 2024 14.51% = 7.77% × 1.87
Dec 31, 2023 14.83% = 7.82% × 1.90
Sep 30, 2023 13.77% = 7.16% × 1.92
Jun 30, 2023 13.88% = 7.04% × 1.97
Mar 31, 2023 15.68% = 7.87% × 1.99
Dec 31, 2022 18.90% = 9.31% × 2.03
Sep 30, 2022 22.11% = 10.84% × 2.04
Jun 30, 2022 23.44% = 11.53% × 2.03
Mar 31, 2022 21.82% = 10.44% × 2.09
Dec 31, 2021 19.75% = 9.40% × 2.10
Sep 30, 2021 21.04% = 9.82% × 2.14
Jun 30, 2021 18.86% = 8.70% × 2.17
Mar 31, 2021 17.06% = 7.86% × 2.17

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The analysis of the quarterly financial ratios over the observed period reveals notable trends in profitability and financial structure.

Return on Assets (ROA)
The ROA showed an increasing trend from the beginning period, rising from 7.86% to a peak near 11.53% within approximately a year and a half. Subsequently, it declined to around 7.04% to 7.82% through the next several quarters. A significant upturn occurred starting in late 2024, with ROA nearly doubling to approximately 16.6% by the end of the most recent quarter. This indicates a marked improvement in asset utilization efficiency in the latest periods.
Financial Leverage
The financial leverage ratio steadily decreased over the entire timeline, moving from 2.17 at the start to 1.65 by the last recorded quarter. This reduction suggests a gradual deleveraging strategy, implying that the company has been lowering its reliance on debt relative to equity.
Return on Equity (ROE)
ROE initially followed an upward trajectory similar to ROA, increasing from 17.06% to a peak of 23.44%, before declining to mid-teens percentages in the subsequent quarters. In the final phase, there was a substantial increase in ROE, reaching over 27% by the end of the period examined. This simultaneous rise in ROE and ROA alongside falling financial leverage suggests the company has enhanced profitability primarily through improved operational performance rather than increased leverage.

In summary, the company experienced initial growth in asset efficiency and shareholder returns, followed by a period of moderate decline, and ended with a striking improvement in both ROA and ROE, accompanied by a consistent reduction in financial leverage. This pattern indicates a focused enhancement in operational effectiveness and a prudent approach to capital structure management.


Three-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Sep 30, 2025 27.43% = 31.88% × 0.52 × 1.65
Jun 30, 2025 27.65% = 32.43% × 0.51 × 1.66
Mar 31, 2025 27.66% = 31.89% × 0.52 × 1.67
Dec 31, 2024 28.12% = 31.95% × 0.52 × 1.71
Sep 30, 2024 14.49% = 13.99% × 0.55 × 1.87
Jun 30, 2024 14.13% = 13.65% × 0.56 × 1.86
Mar 31, 2024 14.51% = 13.96% × 0.56 × 1.87
Dec 31, 2023 14.83% = 14.27% × 0.55 × 1.90
Sep 30, 2023 13.77% = 12.92% × 0.55 × 1.92
Jun 30, 2023 13.88% = 12.83% × 0.55 × 1.97
Mar 31, 2023 15.68% = 13.98% × 0.56 × 1.99
Dec 31, 2022 18.90% = 15.88% × 0.59 × 2.03
Sep 30, 2022 22.11% = 17.52% × 0.62 × 2.04
Jun 30, 2022 23.44% = 18.78% × 0.61 × 2.03
Mar 31, 2022 21.82% = 17.35% × 0.60 × 2.09
Dec 31, 2021 19.75% = 16.42% × 0.57 × 2.10
Sep 30, 2021 21.04% = 17.12% × 0.57 × 2.14
Jun 30, 2021 18.86% = 15.85% × 0.55 × 2.17
Mar 31, 2021 17.06% = 15.33% × 0.51 × 2.17

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Net Profit Margin
The net profit margin demonstrates fluctuations over the observed periods. Initially, there is a gradual increase from approximately 15.33% to a peak near 18.78% in mid-2022. This is followed by a downward trend, reaching a low point around 12.83% in mid-2023. Subsequently, the margin recovers modestly, remaining in the range of approximately 13.65% to 14.27% through late 2024. Notably, a substantial and abrupt increase occurs starting in the final quarter of 2024, with the net profit margin surging to around 32%, where it stabilizes thereafter.
Asset Turnover
The asset turnover ratio shows a progressive improvement from 0.51 in early 2021 to about 0.62 by late 2022, indicating improved efficiency in generating sales from assets. However, it experiences a decline beginning in early 2023, decreasing gradually to approximately 0.51 by late 2025. This suggests a reduction in asset utilization efficiency in the latter periods.
Financial Leverage
Financial leverage exhibits a steady decrease throughout the entire period, declining from around 2.17 at the start of 2021 to roughly 1.65 by the end of 2025. This indicates a consistent reduction in the use of debt relative to equity, signifying a more conservative capital structure over time.
Return on Equity (ROE)
Return on equity mirrors the trends observed in net profit margin, with an initial rise from about 17.06% in early 2021 to a peak of approximately 23.44% in mid-2022. This is followed by a decline reaching roughly 13.77% in late 2023. A period of stabilization and slight growth occurs through 2024. A marked increase is evident starting from the last quarter of 2024, with ROE values climbing sharply to near 28% and maintaining this elevated level through 2025.

Five-Component Disaggregation of ROE

Abbott Laboratories, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Sep 30, 2025 27.43% = 1.72 × 0.94 × 19.72% × 0.52 × 1.65
Jun 30, 2025 27.65% = 1.77 × 0.94 × 19.55% × 0.51 × 1.66
Mar 31, 2025 27.66% = 1.84 × 0.93 × 18.67% × 0.52 × 1.67
Dec 31, 2024 28.12% = 1.91 × 0.93 × 18.05% × 0.52 × 1.71
Sep 30, 2024 14.49% = 0.85 × 0.92 × 17.86% × 0.55 × 1.87
Jun 30, 2024 14.13% = 0.85 × 0.91 × 17.47% × 0.56 × 1.86
Mar 31, 2024 14.51% = 0.86 × 0.91 × 17.76% × 0.56 × 1.87
Dec 31, 2023 14.83% = 0.86 × 0.91 × 18.20% × 0.55 × 1.90
Sep 30, 2023 13.77% = 0.83 × 0.91 × 17.07% × 0.55 × 1.92
Jun 30, 2023 13.88% = 0.82 × 0.91 × 17.11% × 0.55 × 1.97
Mar 31, 2023 15.68% = 0.83 × 0.92 × 18.24% × 0.56 × 1.99
Dec 31, 2022 18.90% = 0.83 × 0.94 × 20.31% × 0.59 × 2.03
Sep 30, 2022 22.11% = 0.85 × 0.95 × 21.87% × 0.62 × 2.04
Jun 30, 2022 23.44% = 0.85 × 0.95 × 23.22% × 0.61 × 2.03
Mar 31, 2022 21.82% = 0.85 × 0.94 × 21.51% × 0.60 × 2.09
Dec 31, 2021 19.75% = 0.86 × 0.94 × 20.30% × 0.57 × 2.10
Sep 30, 2021 21.04% = 0.88 × 0.94 × 20.83% × 0.57 × 2.14
Jun 30, 2021 18.86% = 0.89 × 0.93 × 19.25% × 0.55 × 2.17
Mar 31, 2021 17.06% = 0.90 × 0.92 × 18.54% × 0.51 × 2.17

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The analysis of the quarterly financial ratios reveals several notable trends and patterns over the observed periods. These ratios provide insight into the company’s profitability, efficiency, leverage, and return to equity holders.

Tax Burden
The tax burden ratio generally decreases from 0.9 in early 2021 to around 0.83-0.86 during 2022 and early 2023, indicating a slight decline in the proportion of pre-tax income paid as taxes. However, starting from the end of 2024 and into 2025, there is an abrupt and significant increase in the tax burden ratio, reaching values exceeding 1.7, which is unusual and suggests anomalous or non-recurring tax effects impacting the financial results in these later periods.
Interest Burden
This ratio remains relatively stable over the entire period, fluctuating narrowly between 0.91 and 0.95. This stability indicates consistent expense levels related to interest relative to EBIT, suggesting disciplined management of debt costs.
EBIT Margin
The EBIT margin experiences fluctuations in the range of approximately 17% to 23%. It peaks around mid-2022 before retreating back to the high teens during 2023 and early 2024. In late 2024 and into 2025, the margin exhibits a gradual increase, reaching nearly 20%, which implies improvements in operating profitability after a prior period of margin compression.
Asset Turnover
This efficiency measure shows a pattern of gradual increase from about 0.51 in early 2021 to a peak around 0.62 by late 2022. Thereafter, it declines steadily back to approximately 0.51 by late 2025. The initial improvement indicates better utilization of assets to generate sales, while the subsequent decline suggests a reduction in operational efficiency in asset use over the last periods.
Financial Leverage
The financial leverage ratio shows a declining trend throughout the entire period, falling from over 2.1 in early 2021 to around 1.65 by late 2025. This consistent decrease signifies a reduction in reliance on debt financing or credit, reflecting a more conservative capital structure and potentially lower financial risk.
Return on Equity (ROE)
The ROE demonstrates notable variability, climbing from about 17% in early 2021 to a high above 23% in mid-2022, followed by a decline to under 15% through most of 2023 and early 2024. Remarkably, from late 2024 onward, ROE surges markedly to above 27%, indicating a strong boost in returns to shareholders. This abrupt increase may be linked to the observed rise in tax burden and changes in leverage and profitability components, potentially reflecting extraordinary financial events or adjustments during this timeframe.

Overall, the company displays steady interest expense control and a deliberate reduction in financial leverage, accompanied by fluctuating yet generally resilient profitability margins. Asset utilization improved initially but weakened towards the end of the period. The sudden significant increase in tax burden and ROE towards the final quarters suggests unusual circumstances influencing reported results, warranting further investigation for clarity on underlying causes.


Two-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Sep 30, 2025 16.60% = 31.88% × 0.52
Jun 30, 2025 16.64% = 32.43% × 0.51
Mar 31, 2025 16.58% = 31.89% × 0.52
Dec 31, 2024 16.46% = 31.95% × 0.52
Sep 30, 2024 7.76% = 13.99% × 0.55
Jun 30, 2024 7.61% = 13.65% × 0.56
Mar 31, 2024 7.77% = 13.96% × 0.56
Dec 31, 2023 7.82% = 14.27% × 0.55
Sep 30, 2023 7.16% = 12.92% × 0.55
Jun 30, 2023 7.04% = 12.83% × 0.55
Mar 31, 2023 7.87% = 13.98% × 0.56
Dec 31, 2022 9.31% = 15.88% × 0.59
Sep 30, 2022 10.84% = 17.52% × 0.62
Jun 30, 2022 11.53% = 18.78% × 0.61
Mar 31, 2022 10.44% = 17.35% × 0.60
Dec 31, 2021 9.40% = 16.42% × 0.57
Sep 30, 2021 9.82% = 17.12% × 0.57
Jun 30, 2021 8.70% = 15.85% × 0.55
Mar 31, 2021 7.86% = 15.33% × 0.51

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Net Profit Margin
The net profit margin showed an initial upward trend from March 2021 through June 2022, increasing from 15.33% to a peak of 18.78%. Following this peak, a decline was observed through June 2023, reaching approximately 12.83%. A moderate recovery occurred towards the end of 2023 and into early 2024, with values stabilizing around 13.65% to 14.27%. A significant and abrupt increase is notable starting in December 2024, where the margin surged sharply to around 31.95% and remained consistently above 31.8% thereafter through late 2025.
Asset Turnover
Asset turnover improved steadily from 0.51 in March 2021 to a high of 0.62 by September 2022. Subsequently, a gradual decline occurred, decreasing to approximately 0.55 by December 2023, with slight fluctuations maintaining a range between 0.55 and 0.56 throughout most of 2023 and early 2024. From December 2024 onward, a more pronounced decline developed, reaching a low near 0.51 by September 2025 before a marginal increase to 0.52.
Return on Assets (ROA)
ROA mirrored the initial improvement seen in net profit margin and asset turnover, increasing from 7.86% in March 2021 to a peak of 11.53% in June 2022. Following this peak, ROA declined steadily to around 7.04% in June 2023 but gradually recovered to approximately 7.82% by December 2023 and maintained a relatively stable trend through early 2024. Beginning in December 2024, a substantial increase occurred, with ROA approximately doubling to levels around 16.46%, which persisted consistently through late 2025.
Overall Insights
The financial performance indicators reflect a phase of growth and efficiency gains up to mid-2022, followed by a period of contraction or normalization through 2023 and early 2024. Notably, late 2024 marks a significant inflection point with dramatic improvements in profitability and returns, despite the asset turnover declining notably during this period. This suggests a shift in operating efficiency or profitability margins independent of asset utilization, potentially driven by changes in cost structure, pricing power, or asset base composition. The substantial increase in net profit margin and ROA combined with a decreasing asset turnover ratio indicates enhanced profitability per unit of asset, implying more effective asset use or higher margins on sales during the later period.

Four-Component Disaggregation of ROA

Abbott Laboratories, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Sep 30, 2025 16.60% = 1.72 × 0.94 × 19.72% × 0.52
Jun 30, 2025 16.64% = 1.77 × 0.94 × 19.55% × 0.51
Mar 31, 2025 16.58% = 1.84 × 0.93 × 18.67% × 0.52
Dec 31, 2024 16.46% = 1.91 × 0.93 × 18.05% × 0.52
Sep 30, 2024 7.76% = 0.85 × 0.92 × 17.86% × 0.55
Jun 30, 2024 7.61% = 0.85 × 0.91 × 17.47% × 0.56
Mar 31, 2024 7.77% = 0.86 × 0.91 × 17.76% × 0.56
Dec 31, 2023 7.82% = 0.86 × 0.91 × 18.20% × 0.55
Sep 30, 2023 7.16% = 0.83 × 0.91 × 17.07% × 0.55
Jun 30, 2023 7.04% = 0.82 × 0.91 × 17.11% × 0.55
Mar 31, 2023 7.87% = 0.83 × 0.92 × 18.24% × 0.56
Dec 31, 2022 9.31% = 0.83 × 0.94 × 20.31% × 0.59
Sep 30, 2022 10.84% = 0.85 × 0.95 × 21.87% × 0.62
Jun 30, 2022 11.53% = 0.85 × 0.95 × 23.22% × 0.61
Mar 31, 2022 10.44% = 0.85 × 0.94 × 21.51% × 0.60
Dec 31, 2021 9.40% = 0.86 × 0.94 × 20.30% × 0.57
Sep 30, 2021 9.82% = 0.88 × 0.94 × 20.83% × 0.57
Jun 30, 2021 8.70% = 0.89 × 0.93 × 19.25% × 0.55
Mar 31, 2021 7.86% = 0.90 × 0.92 × 18.54% × 0.51

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Tax Burden
The tax burden ratio exhibits a gradual decline from 0.90 at the beginning of the period to around 0.83 by the end of 2023, indicating a decreasing proportion of earnings lost to taxes over these years. However, from early 2024 onward, there is a marked and unusual increase, reaching values above 1.7 by late 2025. This sharp rise suggests either a significant change in tax strategy or an accounting anomaly requiring further investigation.
Interest Burden
The interest burden ratio remains relatively stable throughout the entire period, fluctuating narrowly around 0.91 to 0.95. This consistency points to steady interest expenses relative to earnings before interest and taxes, indicating no major changes in debt servicing costs or financial leverage.
EBIT Margin
The EBIT margin shows moderate variability, initially rising from approximately 18.5% in early 2021 to a peak near 23.2% in mid-2022. After this peak, a decline follows, with margins dropping back to around 17% by late 2023. Subsequently, the margin recovers gradually, reaching nearly 19.7% by the end of 2025. This pattern reveals periods of improved operational profitability followed by pressure on margins, potentially due to cost fluctuations or pricing dynamics, before stabilizing toward the later years.
Asset Turnover
Asset turnover improves from 0.51 early in 2021 to a high of 0.62 in late 2022, reflecting more effective utilization of assets to generate sales. Thereafter, the ratio slightly declines and stabilizes around 0.51 to 0.56 for the remainder of the period, indicating a potential plateau in operational efficiency or a change in asset base composition.
Return on Assets (ROA)
ROA aligns closely with trends in EBIT margin and asset turnover. It rises significantly from approximately 7.9% in early 2021 to over 11.5% in mid-2022, highlighting enhanced profitability and asset use. This is followed by a reduction to roughly 7.0%-7.8% range through late 2023 and early 2024, and then a dramatic increase to above 16% by the 2025 horizon. Such volatility suggests impactful changes in either operational performance or accounting treatments, necessitating a review of contributing factors behind the surge in 2025.

Disaggregation of Net Profit Margin

Abbott Laboratories, decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Sep 30, 2025 31.88% = 1.72 × 0.94 × 19.72%
Jun 30, 2025 32.43% = 1.77 × 0.94 × 19.55%
Mar 31, 2025 31.89% = 1.84 × 0.93 × 18.67%
Dec 31, 2024 31.95% = 1.91 × 0.93 × 18.05%
Sep 30, 2024 13.99% = 0.85 × 0.92 × 17.86%
Jun 30, 2024 13.65% = 0.85 × 0.91 × 17.47%
Mar 31, 2024 13.96% = 0.86 × 0.91 × 17.76%
Dec 31, 2023 14.27% = 0.86 × 0.91 × 18.20%
Sep 30, 2023 12.92% = 0.83 × 0.91 × 17.07%
Jun 30, 2023 12.83% = 0.82 × 0.91 × 17.11%
Mar 31, 2023 13.98% = 0.83 × 0.92 × 18.24%
Dec 31, 2022 15.88% = 0.83 × 0.94 × 20.31%
Sep 30, 2022 17.52% = 0.85 × 0.95 × 21.87%
Jun 30, 2022 18.78% = 0.85 × 0.95 × 23.22%
Mar 31, 2022 17.35% = 0.85 × 0.94 × 21.51%
Dec 31, 2021 16.42% = 0.86 × 0.94 × 20.30%
Sep 30, 2021 17.12% = 0.88 × 0.94 × 20.83%
Jun 30, 2021 15.85% = 0.89 × 0.93 × 19.25%
Mar 31, 2021 15.33% = 0.90 × 0.92 × 18.54%

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The analysis of the quarterly financial data over the observed periods reveals several notable trends concerning the company's profitability and burden ratios.

Tax Burden
The tax burden ratio shows a general declining trend from March 2021 through December 2024, moving from 0.90 down to approximately 0.85, indicating a decreasing proportion of earnings paid as tax over this timeframe. However, starting in December 2024, the ratio experiences a sharp and significant increase, rising above 1.7 and reaching close to 1.9 by mid-2025. This abrupt change suggests an unusual tax-related event or accounting adjustment affecting this metric.
Interest Burden
The interest burden ratio remains relatively stable throughout the period analyzed, fluctuating slightly between 0.91 and 0.95. This constancy implies that interest expenses relative to earnings before interest and taxes have been consistently managed without large variations, indicating steady financial leverage or debt servicing costs.
EBIT Margin
The EBIT margin exhibits some volatility but generally remains within a narrow band from about 17% to 23%. Initially, there is an upward movement from 18.54% in early 2021 to a peak around 23.22% in mid-2022. This is followed by a decline toward 17% at the end of 2023, then a gradual recovery to approximately 19.72% by the third quarter of 2025. These fluctuations suggest varying operational profitability influenced by changing business conditions or cost structures over the periods.
Net Profit Margin
Net profit margin follows a similar pattern to the EBIT margin but with a more pronounced drop and subsequent spike. From an initial level near 15.33% in early 2021, margin improved to about 18.78% by mid-2022 before declining sharply to approximately 12.8%-14.3% through 2023 and early 2024. Thereafter, a substantial increase is observed starting in late 2024, with margins jumping to nearly 32% by 2025. This considerable rise likely corresponds with the earlier noted anomaly in tax burden, which could indicate exceptional gains, tax credits, or other extraordinary items influencing net profitability.

Overall, the company displays stable interest expenses, moderate variability in operating profitability, and an unusual pattern in tax and net profit margins towards the end of the examined timeline. Such shifts merit further investigation to understand the underlying causes and their implications for fiscal health and future performance.